Moreover, mutant p53 enhances glycolytic GAPDH activity and induces the formation of the SIRT1-GAPDH complex, which can stabilize cytosolic GAPDH for glycolysis and induce tumor growth and survival in PDAC [10]. The gene discussed is GAPDH; the disease is neoplasm.